Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15985 EPS, expectations were $-0.06. Amicus Therapeutics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Perceptive Advisors Joseph Edelman | 28,057,456 | $330,516,832 | 5.74% | |
2. | VenBio Select Advisor Kurt Von Emster | 27,400,000 | $322,772,000 | 3.76% | |
3. | Redmile Group Jeremy Green | 13,257,286 | $156,170,829 | -11% | 5.73% |
4. | Palo Alto Investors William Leland Edwards | 9,344,102 | $110,073,522 | -10% | 12.41% |
5. | StemPoint Capital Michelle Ross | 1,547,141 | $18,225,321 | +80% | 4.81% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$10.49 | 1,500 | Director | 65,082 | 2021-11-01 | Filing | |
$9.56 | 1,500 | Director | 63,582 | 2021-10-01 | Filing | |
$11.41 | 1,500 | Director | 62,082 | 2021-09-01 | Filing | |
$9.28 | 1,500 | Director | 60,582 | 2021-08-02 | Filing | |
$9.24 | 1,500 | Director | 47,467 | 2021-06-01 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$10.00 | 6,100 | 886,654 | 2024-07-05 | Filing | ||
$10.00 | 1,400 | 886,654 | 2024-07-01 | Filing | ||
$10.00 | 7,500 | 886,654 | 2024-06-03 | Filing | ||
$10.07 | 7,500 | 886,654 | 2024-05-01 | Filing | ||
$11.67 | 7,500 | 886,654 | 2024-04-01 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 28,492,486 | $404,308,376 | 0% | |
2. | 22,988,139 | $326,201,690 | 0% | |
3. | 17,848,531 | $253,270,655 | 0.02% | |
4. | 15,190,024 | $215,546,442 | 0.04% | |
5. | 13,327,897 | $189,122,871 | 0.01% |